This is the best summary I could come up with:

Here in the United States, cultivated meat companies saw regulatory doors open widely after the Food and Drug Administration cleared Upside Foods and Good Meat in June to sell their cultivated chicken products across the country, and now both are in restaurants.

Meanwhile, U.K.-based Uncommon, formerly known as Higher Steaks, which also makes a wide assortment of cultivated meats, grabbed $30 million in Series A funding.

Existing investors coming back include BlueYard, Bridford, MilkyWay, DSM Venturing and Wise chairman and founder Taavet Hinrikus.

Since its inception five years ago, the company has grown to a team of 100, started production in Singapore and held the first external tastings of its pork products after The Netherlands gave the green light for companies to organize tastings, Meatable’s co-founder and CEO Krijn de Nood told TechCrunch.

More recently, de Nood unveiled the company’s ability to slash production time it takes to make fat and muscle, from three weeks to eight days, telling AgFunder in May that while rivals are achieving 50-liter bioreactors, Meatable is currently able to reach 500-liter bioreactors and grow cells at 80 million cells per milliliter, thus enabling the company to make fat and muscle within days.

Meanwhile, the new funding will help Meatable, which is still pre-revenue, scale its processes and accelerate the commercialization of its first products, which will include sausages and pork dumplings, in Singapore starting in 2024, de Nood said.

I’m a bot and I’m open source!